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Abstract
The global health community is interested in the health impact of the billions of dollars invested to
fight malaria in Africa. A recent publication used trends in malaria cases and deaths based on health
facility records to evaluate the impact of malaria control efforts in Rwanda and Ethiopia. Although
the authors demonstrate the use of facility-based data to estimate the impact of malaria control
efforts, they also illustrate several pitfalls of such analyses that should be avoided, minimized, or
actively acknowledged. A critique of this analysis is presented because many country programmes
and donors are interested in evaluating programmatic impact with facility-based data. Key concerns
related to: 1) clarifying the objective of the analysis; 2) data validity; 3) data representativeness; 4)
the exploration of trends in factors that could influence malaria rates and thus confound the
relationship between intervention scale-up and the observed changes in malaria outcomes; 5) the
analytic approaches, including small numbers of patient outcomes, selective reporting of results,
and choice of statistical and modeling methods; and 6) internal inconsistency on the strength and
interpretation of the data. In conclusion, evaluations of malaria burden reduction using facility-
based data could be very helpful, but those data should be collected, analysed, and interpreted with
care, transparency, and a full recognition of their limitations.
Background
Otten and colleagues [1] recently published an evaluation
of the impact of malaria control in Rwanda and Ethiopia.
This article is timely, as the global health community has
considerable interest in the health impact of the billions
of dollars invested to fight malaria in Africa. To date, few
evaluations have been published, mostly of malaria pro-
grammes in relatively small islands, such as Bioko [2] and
Zanzibar [3]. Otten and colleagues present trends in
malaria cases and deaths from health facility records as
evidence that the scale-up of long-lasting insecticidal nets
(LLINs) and case management with artemisinin-based
combination therapy (ACT) reduced the burden of
malaria. Although the authors demonstrate the use of
facility-based data to estimate the impact of malaria con-
trol efforts, they also illustrate several pitfalls of such anal-
yses that should be avoided, minimized, or actively
acknowledged. While news of malaria control success is
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appreciated, in this Commentary, a critique of this analy-
sis is presented because many country programmes and
donors are interested in evaluating programmatic impact
with facility-based data, which are available in most coun-
tries in sub-Saharan Africa.
Discussion
The ideal method for assessing impact requires that
observed changes in malaria morbidity and mortality
(based on perfectly valid data) are attributed to exposure
to an intervention(s). An experimental study design is
needed to assess what would have happened had that
exposure never occurred. Although it is highly unlikely
that evaluations of real-world programmes would involve
such methods, an examination of how an evaluation devi-
ates from the ideal can be used to judge the evaluation's
validity. Note that it should be mentioned that pro-
gramme evaluations can still be robust even if ideal exper-
imental designs are not used.
The first concern of the evaluation by Otten and col-
leagues is that it is unclear whether the objective was to
assess the programmatic impact on the malaria burden at
health facilities or in communities. The background states
that the authors intended to assess the impact of malaria
control on "health facility burdens"; however the article
does not explain what this means, and the implication is
that the facility-based results reflect malaria trends in the
community. Although the terms "health facility burden"
and "community burden" might not have formally recog-
nized definitions, the former typically refers to caseloads
(e.g., cases of malaria and anaemia), commodity use, and
costs incurred in health facilities; and the latter means
malaria cases and deaths in the general population. While
both types of burden are important, a trend in one does
not necessarily imply a corresponding trend in the other.
For example, a community case-management programme
that primarily shifts care-seeking from facilities to village-
level providers could decrease the health facility burden
with little effect on the community burden. More impor-
tantly, while accurate and complete health facility records
are an excellent data source for evaluating changes in the
health facility burden, these data might not produce valid
trends for the community burden.
The second concern is that a lack of detail in the article
makes it difficult to judge the validity of the data. For
example, in Rwanda, the statement that "all sampled facil-
ities performed malaria smears on all suspected malaria
cases" does not seem plausible. Not a single patient was
missed--even during weekends and evenings? Nationally,
according to Rwanda's Health Management Information
System, in 2007, only 45% of facility-based malaria cases
were laboratory-confirmed [4]. Also, in 2006, Rwanda
adopted the World Health Organization's Integrated
Management of Childhood Illness strategy [5], which
does not recommend routine malaria testing for children
with a febrile illness who are under five years of age. With
such a strategy, most children would not be tested.
Accounting for testing trends is critical because increased
testing can dramatically decrease the incidence of malaria
diagnoses (i.e., malaria is increasingly ruled out among
patients with febrile illness that might have been previ-
ously reported as malaria cases), and both countries
recently made efforts to increase malaria testing. Addi-
tionally, the article did not describe the quality of diag-
nostic testing (e.g., sensitivity and specificity) and whether
quality changed over time or differed from place to place.
Changes in testing quality could bias trends in malaria
outcomes (e.g., microscopy training that decreased false-
positives would lead to declines in observed cases even if
the true rate was unchanged). It would have been helpful
if the authors had described how they determined that all
suspected cases were tested and characterized the use and
quality of diagnostic testing over time. Data validity was
even more difficult to assess for Ethiopia, as laboratory
examinations were not recorded among outpatients and
the availability of laboratory data for inpatients was not
mentioned.
Third, the sampling procedures make it difficult to assess
the representativeness of the data. The authors stratified
their convenience sample so that selected facilities would
be spread out across malarious areas of both countries.
However, the selection of "sites where intervention scale-
up had been relatively rapid and successful and where
health facility data were of relatively good quality" sug-
gests that results were biased toward areas likely to have a
relatively greater impact. Additionally, the number of
health facilities was small: 19 in Rwanda and 13 in Ethio-
pia. With such small samples, even the use of probability
sampling does not guard against skewed results.
Fourth, the analysis did not include trends in factors that
could influence malaria rates and thus confound the rela-
tionship between LLIN and ACT scale-up and the
observed changes in malaria outcomes. Key examples of
such factors are rainfall, implementation of a home-based
fever treatment strategy, and indoor residual spraying--all
of which could have changed the rate of malaria cases
seen at health facilities, but not necessarily cases of other
illnesses. Even a simple graph of such trends over time
together with the malaria outcomes can be helpful in
understanding the potential effect of these factors (see
example in Bhattarai and colleagues [3]).
Fifth, some of the analytic approaches raised concerns. For
example, at least one conclusion was based on a very
small number of patient outcomes. In Ethiopia, for chil-
dren under five years of age, the reported impact on inpa-Malaria Journal 2009, 8:209 http://www.malariajournal.com/content/8/1/209
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tient deaths was based on a decrease of 11 deaths per year
during the reference period to four deaths in 2007.
Another issue with the analytic approach was that there
appeared to be some selective reporting of results, in
which decreases in malaria (e.g., from 2005-2007 in Fig-
ure four, and from 2006-2007 in Figure five) were attrib-
uted to the scale-up of LLINs and ACT, but similar
decreases (e.g., from 2001-2002 in Figure four, and from
early 2001-2003 in Figure five) were not discussed.
Additionally, the statistical methods were not ideal and
might have led to an underestimation of uncertainty. The
methods did not account for the correlated nature of the
data (i.e., the data were repeated measures of the malaria
caseload at selected health facilities over time), and a fail-
ure to adjust for correlation (e.g., with generalized esti-
mating equations or a random-effects model) could make
results appear more precise than they actually are.
Another statistical issue was the use of linear regression to
model counts when a non-linear model (e.g., based on a
Poisson or negative binomial distribution) would have
been more appropriate. For example, if the trend for inpa-
tient cases in Figure four continued for another year or
two, a linear model probably would have predicted a neg-
ative case count (obviously impossible). Perhaps, if more
suitable methods had been used, the decline of outpatient
malaria cases in Ethiopia, adjusted for linear trend (69%;
95% confidence interval: 45-83%), would no longer be
statistically significant. Indeed, to us, the 2007 data point
of outpatient malaria cases in Figure four appeared to be
simply a continuation of the sharp decline seen in the pre-
ceding years.
Finally, there is internal inconsistency in the report on the
strength and interpretation of the data. Specifically,
although the discussion appropriately states that a variety
of factors in Ethiopia "make it impossible to draw firm
conclusions yet regarding the causal relationship between
the observed malaria declines and LLIN and ACT scale-
up," the abstract's conclusion was that: "Initial evidence
indicated that the combination of mass distribution of
LLIN to all children < 5 years or all households and
nationwide distribution of ACT in the public sector was
associated with substantial declines of in-patient malaria
cases and deaths in Rwanda and Ethiopia." Readers who
only saw the abstract could easily conclude incorrectly
that the evidence showed that scale-up led to a reduction
of the burden in Ethiopia.
Conclusion
It is exciting that interventions to control malaria are
being scaled-up across Africa and that the coming years
will likely be rich with evaluations demonstrating reduc-
tions in malaria's terrible burden. Evaluations of malaria
burden reduction using facility-based data could be very
helpful--especially when used in conjunction with repre-
sentative community-based surveys of intervention cover-
age, all-cause child mortality, and biomarkers, such as
parasite prevalence and anaemia. However, facility-based
data need to be collected, analysed, and interpreted with
care, transparency, and a full recognition of their limita-
tions. Many of these issues are described in greater detail
in a guidance document from the Monitoring and Evalu-
ation Reference Group of the Roll Back Malaria Partner-
ship [6], and an inter-agency task force is currently
exploring these issues in depth with the goal of providing
practical recommendations (personal communication
from S. Yoon, CDC, March 10, 2009).
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